Skip to main content

Table 1 General characteristics at admission and inclusion

From: Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial

 

Control

Preload dependence

P

(n = 30)

(n = 30)

Age (years)

64 [54-76]

65 [58-80]

0.38

Male gender

22 (73%)

21 (70%)

1

Admission category

   

  Medical

27 (90%)

30 (100%)

0.24

  Unscheduled surgery

3 (10%)

0 (0%)

 

Charlson score

3 [2-5]

3 [1-5]

0.74

Immunodeficiency*

9 (30%)

9 (30%)

1

SAPS II

56 [50-60]

57 [47-69]

0.55

SOFA score at inclusion

10 [9-12]

11 [9-13]

0.52

Time between hypotension and inclusion (H)

9 [5-11]

10 [6-11]

0.64

Time between ICU admission and inclusion (H)

8 [4-15]

6 [3-12]

0.55

Renal replacement therapy

6 (20%)

8 (27%)

0.76

Mechanical ventilation

26 (87%)

20 (67%)

0.13

Volume of IV fluids administered between hypotension and inclusion (L)

3.0 [2.5-4.0]

3.5 [2.5-4.4]

0.26

Type of infection

   

  Community-acquired infection

23 (77%)

21 (70%)

0.77

  Hospital-acquired infection

7 (23%)

9 (30%)

 

Infection site

   

  Pulmonary

16 (53%)

18 (60%)

0.80

  Intra-abdominal

5 (17%)

7 (23%)

0.75

  Urinary tract

3 (10%)

6 (20%)

0.47

  Catheter-related infection

1 (3%)

3 (10%)

0.61

  Other

3 (10%)

4 (13%)

1

Positive blood cultures

15 (50%)

15 (50%)

1

Identification of causative pathogen

25 (83%)

27 (90%)

0.71

Causative pathogens

   

  Enterobacteriaceae

13 (43%)

16 (53%)

0.61

  Non-fermenting gram-negative bacilli

5 (17%)

3 (10%)

0.71

  Other gram-negative bacilli

2 (7%)

4 (13%)

0.67

  Staphylococci

6 (20%)

7 (23%)

1

  Streptococci

2 (7%)

6 (20%)

0.25

  Gram-positive bacilli

0 (0%)

1 (3%)

1

  Enterococci

0 (0%)

1 (3%)

1

  Gram-negative cocci

0 (0%)

1 (3%)

1

  Fungi

0 (0%)

1 (3%)

1

Empirical antibiotic therapy

   

  Adequate

24 (80%)

23 (77%)

0.42

  Inadequate

1 (3%)

4 (13%)

 

  Not applicable

5 (17%)

3 (10%)

 
  1. Data are median [interquartile range] or number of patients (%). *immunodeficiency was considered in any of the following situations: chronic treatment with steroids or other immunosuppressive agents, chemotherapy within one month, infection with the human immunodeficiency virus, neutropenia below 0.5 G.L-1, or past history of splenectomy. SAPS II, Simplified Acute Physiology Score II [20]; SOFA, Sequential Organ Failure Assessment score [21]; ICU, intensive care unit; IV, intravenous.